Cite
HARVARD Citation
Miniotti, M. et al. (2022). Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis. Dermatologic therapy. 35 (5), p. n/a. [Online].